In explaining the rationale behind the study, Tang and colleagues pointed out that despite the lack of level 1 evidence, MDT ...

A cancer specialist explains the subtle warning signs that are easy to dismiss ...

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

Numerous men write off early symptoms of Prostate Cancer as part of the aging process. Recognizing these signs and seeking ...

Risk of death and cause of death 30 years after diagnosis as a proportion of 100 men. Grey figures indicate the proportion of men alive after 30 years, blue figures the proportion of men who died of ...

Former President Joe Biden has been diagnosed with a form of prostate cancer that has been described as “aggressive.” Obviously, that’s not good news for him and his family, but what does it mean in ...

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

"We found that preexisting depression was associated with a 2.5-fold increase in mortality risk for patients with PCa, highlighting its role in exacerbating disease progression and worsening survival.

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Oxybutynin, a common drug to manage overactive bladder, may help alleviate hot flash symptoms among men receiving androgen ...

Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...

Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.